Esomeprazole Magnesium trihydrate

TargetMol
Product Code: TAR-T8386
Supplier: TargetMol
CodeSizePrice
TAR-T8386-5mg5mg£99.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8386-10mg10mg£112.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8386-1mL1 mL * 10 mM (in DMSO)£115.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8386-25mg25mg£137.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8386-50mg50mg£167.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8386-100mg100mg£213.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8386-200mg200mg£282.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8386-500mg500mg£437.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Esomeprazole Magnesium trihydrate is a proton pump inhibitor indicated for the short-term treatment of gastroesophageal reflux disease in patients with a history of erosive esophagitis.Esomeprazole magnesium trihydrate acts as an exosome inhibitor by blocking the exosome release via the inhibition of V-H+-ATPases
CAS:
217087-09-7
Formula:
C34H42MgN6O9S2
Molecular Weight:
767.17
Pathway:
Membrane transporter/Ion channel
Purity:
0.9871
SMILES:
O.O.O.[Mg++].COc1ccc2[n-]c(nc2c1)S(=O)Cc1ncc(C)c(OC)c1C.COc1ccc2[n-]c(nc2c1)S(=O)Cc1ncc(C)c(OC)c1C
Target:
Proton pump

References

Johnson TJ, Hedge DD. Esomeprazole: a clinical review. Am J Health Syst Pharm. 2002 Jul 15;59(14):1333-9. Sandstr?M M , Davidson G , Tolia V , et al. Phase I, Multicenter, Randomized, Open-Label Study Evaluating the Pharmacokinetics and Safety Profile of Repeated Once-Daily Doses of Intravenous Esomeprazole in Children 0 to 17 Years of Age[J]. Clinical Therapeutics, 2012, 34(8):1828-1838.